|
Poniard Pharmaceuticals Inc - Premium Company Profile (Datamonitor)
Market: Healthcare and Medical
Published Date: 22/04/2008
Market Research Report Title: Poniard Pharmaceuticals Inc - Premium Company Profile
Table of Contents: View
Report Type: Company Profile
Country: Global
Number of Pages: 41
|
Enquire about Report |
Summary: Introduction
Poniard Pharmaceuticals, formerly known as NeoRx Corporation, is a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapy products. The company’s lead product candidate, Picoplatin, is currently in Phase III clinical development for small cell lung cancer and offers a huge opportunity for the company to achieve its first commercial success.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies Highlights
The company’s product pipeline includes single product, Picoplatin, a new generation cytotoxic platinum compound that provides a differentiated spectrum of activity and an improved safety profile. Picoplatin is being developed for small cell lung cancer (Phase III), colorectal cancer (Phase II), and prostate cancer (Phase II).The company does not have any significant ongoing revenue sources till date. On occasion, the company derives revenues from the sale or licensing of its patented technologies and from government grants.The company’s total revenues decreased from $11.1 million in 2002 to absolute zero in 2006. For the fiscal 2006, the company did not recognize any revenues due to non-recognition of any royalties for licensed intellectual property as recognized in 2004 and 2005 from Boston Scientific.Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization
Reports are normally delivered on the same day, via email, if purchased by debit/credit card. Reports purchased by invoice will be released when payment has been received. When you place an order through Google Checkout, Google Checkout will display a price approximation in your local currency. Keep in mind that you'll still be charged in the currency displayed on companiesandmarkets.com. Your debit/credit card company might convert the charge to your local currency and may also add additional fees that are not reflected in the approximate price displayed.
www.companiesandmarkets.com is a central source of market research reports from the world’s leading analysts and report publishers. Companiesandmarkets.com contains a comprehensive range of specialised market research reports from leading publishers for all market sectors.
